57
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Sildenafil use and increased risk of incident melanoma in US men: a prospective cohort study.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The RAS/RAF/mitogen-activated protein kinase and extracellular signal-regulated kinase (ERK) kinase/ERK cascade plays a crucial role in melanoma cell proliferation and survival. Sildenafil citrate (Viagra) is a phosphodiesterase (PDE) 5A inhibitor commonly used for erectile dysfunction. Recent studies have shown that BRAF activation down-regulates PDE5A levels, and low PDE5A expression by BRAF activation or sildenafil use increases the invasiveness of melanoma cells, which raises the possible adverse effect of sildenafil use on melanoma risk.

          Related collections

          Author and article information

          Journal
          JAMA Intern Med
          JAMA internal medicine
          2168-6114
          2168-6106
          Jun 2014
          : 174
          : 6
          Affiliations
          [1 ] Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts2Department of Dermatology, Rhode Island Hospital, Warren Alpert Medical School, Brown University, Providence.
          [2 ] Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts2Department of Dermatology, Rhode Island Hospital, Warren Alpert Medical School, Brown University, Providence3Channing Division of Network Medicine, Depa.
          [3 ] Department of Dermatology, Massachusetts General Hospital, Boston5Graduate Program in Biological and Biomedical Sciences, Harvard Medical School, Boston, Massachusetts.
          [4 ] Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts3Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts6Department of.
          Article
          1857095 NIHMS630158
          10.1001/jamainternmed.2014.594
          24710960
          9fd5657a-68fd-4b3d-8be3-1c176107f94c
          History

          Comments

          Comment on this article